Supplementary Material for: Identification and mapping real-world data sources for heart failure, acute coronary syndrome, and atrial fibrillation
Rachel Studer(Novartis (Switzerland)), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Claudio Sartini(Bayer (Germany)), Rajeev Agrawal, Richard Dobson(University of London), Spiros Denaxas(University of London), Simrat Gill(University Hospitals Birmingham NHS Foundation Trust), Kiliana Suzart‐Woischnik(Bayer (Germany)), Asselbergs F.W., Wirta S.B., H. Natani(Novartis (India))
Cited by 0
Related Papers
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k